These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1530674)

  • 1. Cardiovascular effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitropheny l) octyl ester.
    Hojo M; Teramoto N; Hata H; Katayama O; Tatsumi H; Shibata S
    Arzneimittelforschung; 1992 May; 42(5):621-8. PubMed ID: 1530674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
    Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
    Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
    Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
    Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute antihypertensive effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)-carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitrophen yl) octyl ester on conscious spontaneously hypertensive rats and renal hypertensive rats.
    Hojo M; Tanaka Y; Katayama O; Teramoto N
    Arzneimittelforschung; 1993 Aug; 43(8):847-51. PubMed ID: 8216440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
    Nishikibe M; Nagura J; Kamei K; Fukuroda T
    Arch Int Pharmacodyn Ther; 1988; 291():7-20. PubMed ID: 3365068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
    Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
    Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
    Pruneau D; Roy F; Brown NL
    Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
    Sakanashi M; Noguchi K; Kato T; Sunagawa R; Nagamine F; Nakasone J
    Arzneimittelforschung; 1986 Dec; 36(12):1736-9. PubMed ID: 3566835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
    Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs.
    Nakaya H; Kanno M
    Arzneimittelforschung; 1982; 32(6):626-9. PubMed ID: 7202368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs.
    Murata S; Kikkawa K; Yabana H; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):521-5. PubMed ID: 3401267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.
    Sakanashi M; Noguchi K; Miyamoto Y; Kato T; Nagamine F; Yu WY; Higuchi M; Nakasone J
    Arch Int Pharmacodyn Ther; 1988; 294():159-74. PubMed ID: 2976588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of a new dihydropyridine calcium antagonist.
    Kimura Y; Fukui H; Tanaka M; Okamoto M; Miura A; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1336-44. PubMed ID: 3790183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
    Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
    Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effect of the new dihydropyridine calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedica rbo xylate hydrochloride in dogs.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Apr; 42(4):513-8. PubMed ID: 1642675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.